Human Genome Sciences, Inc.
Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The company's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. Human Genome Sciences was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Rockville, MD.